Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Breast Cancer

Free Subscription Articles published in Int J Radiat Oncol Biol Phys Retrieve available abstracts of 154 articles: HTML format

Single Articles

March 2023
1. HEPEL JT, Loap P, Fourquet A, Kirova YM, et al
   DCIS Update: Escalation or De-escalation? Boost, Fractionation, and Omission of Radiation.
   Int J Radiat Oncol Biol Phys. 2023;115:813-816.
   PubMed    
   
   
   
2. REDDY JP, Lei X, Bloom ES, Reed VK, et al
   Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase 2 Trial of Daily Partial Breast Irradiation.
   Int J Radiat Oncol Biol Phys. 2023;115:629-644.
   PubMed     Abstract available
   
   
   
3. CHATTERJEE S, Chakrabarty S, Santosham R, Saha A, et al
   Alleviating morbidity from locally advanced breast cancer using a practical and short radiotherapy regime: Results of the HYPORT palliative studies.
   Int J Radiat Oncol Biol Phys. 2023 Mar 1:S0360-3016(23)00154.
   PubMed     Abstract available
   
   
   
4. HOLT F, Probert J, Darby S, Haviland JS, et al
   Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.
   Int J Radiat Oncol Biol Phys. 2023 Mar 1:S0360-3016(23)00168.
   PubMed     Abstract available
   
   
   February 2023
5. LIVERINGHOUSE CL, Mills MN, Ahmed KA, Washington IR, et al
   Phase II Study of Preoperative Stereotactic Ablative Body Radiotherapy for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiotherapy.
   Int J Radiat Oncol Biol Phys. 2023 Feb 14:S0360-3016(22)03689.
   PubMed     Abstract available
   
   
   
6. PARK YI, Chang JS, Ko H, Im SH, et al
   Development and validation of a normal tissue complication probability model for lymphedema after radiotherapy in breast cancer.
   Int J Radiat Oncol Biol Phys. 2023 Feb 3:S0360-3016(23)00106.
   PubMed     Abstract available
   
   
   January 2023
7. SHI JJ, Lei X, Chen YS, Chavez-MacGregor M, et al
   Socioeconomic Barriers to Randomized Clinical Trial Retention in Patients Treated with Adjuvant Radiation for Early-Stage Breast Cancer.
   Int J Radiat Oncol Biol Phys. 2023 Jan 29:S0360-3016(23)00079.
   PubMed     Abstract available
   
   
   
8. VASSANTACHART A, Ragab O, Miller K, Lock D, et al
   Knowledge and understanding of radiation therapy among breast cancer patients from culturally diverse backgrounds at a safety-net hospital.
   Int J Radiat Oncol Biol Phys. 2023 Jan 28:S0360-3016(23)00077.
   PubMed     Abstract available
   
   
   
9. WARD MC, Fasola CE, White RL Jr, Bentzen SM, et al
   In Regard to Vaidya et al.
   Int J Radiat Oncol Biol Phys. 2023;115:255-256.
   PubMed    
   
   
   
10. WOODWARD WA, Mitchell MP
    The Elusive Prize of Radiation Therapy Predictive Assays in Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2023;115:103-105.
    PubMed    
    
    
    
11. GOLDBERG M, Bridhikitti J, Khan AJ, McGale P, et al
    A Meta-Analysis of Trials of Partial Breast Irradiation.
    Int J Radiat Oncol Biol Phys. 2023;115:60-72.
    PubMed     Abstract available
    
    
    
12. VICINI FA, Mann GB, Shah C, Weinmann S, et al
    A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023;115:93-102.
    PubMed     Abstract available
    
    
    
13. VAIDYA JS, Bulsara M, Wenz F, Sperk E, et al
    The TARGIT-A Randomized Trial: TARGIT-IORT Versus Whole Breast Radiation Therapy: Long-Term Local Control and Survival.
    Int J Radiat Oncol Biol Phys. 2023;115:77-82.
    PubMed    
    
    
    December 2022
14. WANG B, Liu W, Liu C, Du K, et al
    Cancer-associated fibroblasts promote radioresistance of breast cancer cells via the HGF/c-Met signaling pathway.
    Int J Radiat Oncol Biol Phys. 2022 Dec 28:S0360-3016(22)03679.
    PubMed     Abstract available
    
    
    
15. WARD MC, Recht A, Vicini F, Al-Hilli Z, et al
    Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone vs. Endocrine Therapy Alone or Combined Treatment for Low-Risk ER-positive Early-Stage Breast Cancer in Women Age 65 and Older.
    Int J Radiat Oncol Biol Phys. 2022 Dec 28:S0360-3016(22)03678.
    PubMed     Abstract available
    
    
    
16. ATHALE J, Broderick K, Wu X, Grossman S, et al
    Evidence for Persistent Radiation Related Injury to the Immune System in Patients with Local Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Dec 14:S0360-3016(22)03556.
    PubMed     Abstract available
    
    
    
17. KATIPALLY RR, Olson AC, Chmura SJ
    Flipping the Null: Lessons From Breast Cancer and Recalibrating Expectations in Oligometastases.
    Int J Radiat Oncol Biol Phys. 2022;114:840-842.
    PubMed    
    
    
    November 2022
18. BATENBURG MCT, van der Molen DRM, van der Leij F, Doeksen A, et al
    Patient-reported symptoms of late toxicity in breast cancer patients treated with hypofractionated radiotherapy and the association with quality of life.
    Int J Radiat Oncol Biol Phys. 2022 Nov 16:S0360-3016(22)03523.
    PubMed     Abstract available
    
    
    
19. GOODMAN CR, Strauss JB
    One Way or Another: An Oligorecurrence After an Oligometastasis of an Estrogen Receptor-Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022;114:571-572.
    PubMed    
    
    
    
20. JING H, Tang Y, Wang ZZ, Wei R, et al
    Individualized Clinical Target Volume for Irradiation of the Supraclavicular Region in Breast Cancer Based on Mapping of the Involved Ipsilateral Supraclavicular Lymph Nodes.
    Int J Radiat Oncol Biol Phys. 2022 Nov 8. pii: S0360-3016(22)03513.
    PubMed     Abstract available
    
    
    
21. ALCORN SR, Wright JL
    Toxicity and Timing of Breast Radiation Therapy With Overlapping Systemic Therapies.
    Int J Radiat Oncol Biol Phys. 2022;114:377-381.
    PubMed    
    
    
    
22. AL-RASHDAN A, Quirk S, Roumeliotis M, Abedin T, et al
    Radiation Therapy With Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study.
    Int J Radiat Oncol Biol Phys. 2022;114:399-408.
    PubMed     Abstract available
    
    
    
23. BARNETT GC, Kerns SL, Dorling L, Fachal L, et al
    No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
    Int J Radiat Oncol Biol Phys. 2022;114:494-501.
    PubMed     Abstract available
    
    
    October 2022
24. HARDY-ABELOOS C, Karp J, Xiao J, Oh C, et al
    Disparities in the uptake of telemedicine and implications for clinical trial enrollment in breast cancer patients.
    Int J Radiat Oncol Biol Phys. 2022 Oct 20. pii: S0360-3016(22)03447.
    PubMed     Abstract available
    
    
    
25. ANAKWENZE AKINFENWA CP, Strom EA
    From the Plexus to the Cord: A Case of Metastatic Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022;114:181-182.
    PubMed    
    
    
    September 2022
26. ZHANG YH, Montagna G, Flynn J, Gillespie EF, et al
    Outcomes of Breast Cancer Patients with High Volume of Residual Disease Following Neoadjuvant Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2022 Sep 22. pii: S0360-3016(22)03390.
    PubMed     Abstract available
    
    
    
27. LIU J, Chen YJ, Williams TM, Fields E, et al
    Evaluation of Radiation Oncologist and Trainee Opinions on Residency Expansion, Possible Actions, and Training Program Accreditation Changes in the United States.
    Int J Radiat Oncol Biol Phys. 2022;114:16-20.
    PubMed     Abstract available
    
    
    
28. KAPADIA NS, Brooks GA, Landrum MB, Riedel L, et al
    Association of the Oncology Care Model With Value-Based Changes in Use of Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;114:39-46.
    PubMed     Abstract available
    
    
    August 2022
29. HASSAN MZO, Awadalla M, Tan TC, Scherrer-Crosbie M, et al
    Serial Measurement of Global Longitudinal Strain among Women with Breast Cancer treated with Proton Radiation Therapy: A Prospective Trial for 70 Patients.
    Int J Radiat Oncol Biol Phys. 2022 Aug 23. pii: S0360-3016(22)03141.
    PubMed     Abstract available
    
    
    
30. JACOMINA LE, Eala MAB, Mejia MBA, Baldivia KH, et al
    Utilization of Hypofractionated Radiation Therapy for Breast Cancer: Perspectives From the Philippines.
    Int J Radiat Oncol Biol Phys. 2022;113:925-927.
    PubMed    
    
    
    July 2022
31. SIMONETTO C, Kaiser JC, van den Bogaard VAB, Langendijk JA, et al
    Breast cancer radiotherapy and the risk of acute coronary events - insights from a process oriented model.
    Int J Radiat Oncol Biol Phys. 2022 Jul 1. pii: S0360-3016(22)00645.
    PubMed     Abstract available
    
    
    
32. AL-RASHDAN A, Cao J
    A Viewpoint on Isolated Contralateral Axillary Lymph Node Involvement by Breast Cancer: Regional Recurrence or Distant Metastasis?
    Int J Radiat Oncol Biol Phys. 2022;113:489.
    PubMed    
    
    
    
33. MAILHOT VEGA RB, Wang S, Brooks ED, Oladeru OT, et al
    Evaluating Regional Nodal Irradiation Allocation and Association with Oncologic Outcomes in NSABP B-18, B-27, B-40, and B-41.
    Int J Radiat Oncol Biol Phys. 2022;113:542-551.
    PubMed     Abstract available
    
    
    
34. JACOBS DHM, Mast ME, Horeweg N, Speijer G, et al
    Accelerated Partial Breast Irradiation Using External Beam or Intraoperative Electron Radiation Therapy: 5-Year Oncological Outcomes of a Prospective Cohort Study.
    Int J Radiat Oncol Biol Phys. 2022;113:570-581.
    PubMed     Abstract available
    
    
    June 2022
35. LAPEN K, King C, Braunstein LZ, Khan AJ, et al
    A Comparison of Patient- and Clinician-Reported Acute Toxicity During Radiotherapy for Primary Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jun 5. pii: S0360-3016(22)00548.
    PubMed     Abstract available
    
    
    
36. ZHAO XR, Fang H, Jing H, Tang Y, et al
    Radiation-induced hypothyroidism in patients with breast cancer after hypofractionated radiotherapy: A prospective cohort study.
    Int J Radiat Oncol Biol Phys. 2022 Jun 5. pii: S0360-3016(22)00557.
    PubMed     Abstract available
    
    
    
37. DILWORTH JT, Griffith KA, Pierce LJ, Jagsi R, et al
    The Impact of Chemotherapy on Toxic Effects and Cosmetic Outcome in Patients Receiving Whole Breast Irradiation: An Analysis Within a Statewide Quality Consortium.
    Int J Radiat Oncol Biol Phys. 2022;113:266-277.
    PubMed     Abstract available
    
    
    May 2022
38. ZHANG L, Liu J, Ma J, Mei X, et al
    Entire versus Medial Supraclavicular Nodal Irradiation for Patients with High-risk Node-positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 May 30. pii: S0360-3016(22)00479.
    PubMed     Abstract available
    
    
    
39. SHUKLA U, Sueyoshi M, Diamond B, Chowdhury I, et al
    Disparities in Radiation Therapy: Practice Patterns Analysis of Deep Inspiratory Breath Hold Use in Non-English Speakers.
    Int J Radiat Oncol Biol Phys. 2022;113:21-25.
    PubMed     Abstract available
    
    
    April 2022
40. ZUREICK AH, Grzywacz VP, Almahariq MF, Silverman BR, et al
    Dose to the Left Anterior Descending Artery Correlates with Cardiac Events Following Irradiation for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Apr 25. pii: S0360-3016(22)00332.
    PubMed     Abstract available
    
    
    
41. DOSANI M, Hamilton S, Gondara L, Speers C, et al
    pN0(i+) and pN1mi Breast Cancer: Treatment and Outcomes in Comparison to pN0 and pN1a in the Modern Era.
    Int J Radiat Oncol Biol Phys. 2022 Apr 3. pii: S0360-3016(22)00275.
    PubMed     Abstract available
    
    
    
42. MIGNOT F, Quero L, Guillerm S, Benadon B, et al
    Ten-Year Outcomes of Hypofractionated Postmastectomy Radiation Therapy of 26 Gy in 6 Fractions.
    Int J Radiat Oncol Biol Phys. 2022;112:1105-1114.
    PubMed     Abstract available
    
    
    March 2022
43. ANDRING LM, Diao K, Sun S, Patel M, et al
    Locoregional Management and Prognostic Factors in Breast Cancer Patients with Ipsilateral Internal Mammary and Axillary Lymph Node Involvement.
    Int J Radiat Oncol Biol Phys. 2022 Mar 3. pii: S0360-3016(22)00192.
    PubMed     Abstract available
    
    
    
44. NICHOL A, Narinesingh D, Wade L, Raman S, et al
    Breast Tangent Beam Energy, Surgical Bed-to-Skin Distance and Local Recurrence After Breast-Conserving Treatment.
    Int J Radiat Oncol Biol Phys. 2022;112:671-680.
    PubMed     Abstract available
    
    
    February 2022
45. VERBANCK S, Van Parijs H, Schuermans D, Vinh-Hung V, et al
    Lung Restriction in Breast Cancer Patients after Hypofractionated Tomotherapy and Conventional 3D Conformal Radiotherapy: a 10-year Follow-up.
    Int J Radiat Oncol Biol Phys. 2022 Feb 25. pii: S0360-3016(22)00167.
    PubMed     Abstract available
    
    
    
46. CHAPMAN BV, Liu D, Shen Y, Olamigoke OO, et al
    Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation.
    Int J Radiat Oncol Biol Phys. 2022;112:426-436.
    PubMed     Abstract available
    
    
    
47. CHAPMAN BV, Liu D, Shen Y, Olamigoke OO, et al
    Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing.
    Int J Radiat Oncol Biol Phys. 2022;112:437-444.
    PubMed     Abstract available
    
    
    January 2022
48. ABRAHAM A, Sanghera KP, Gheisari F, Koumna S, et al
    Is radiation-induced cardiac toxicity reversible? Prospective evaluation of breast cancer patients enrolled in a phase-III randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2022 Jan 24. pii: S0360-3016(22)00065.
    PubMed     Abstract available
    
    
    
49. WARD MC, Bentzen SM, Fasola CE, Khan AJ, et al
    An Estimate of Local Failure in the TARGIT-A Trial of Pre-pathology Intraoperative Radiation Therapy for Early Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jan 19. pii: S0360-3016(21)03434.
    PubMed     Abstract available
    
    
    
50. BELLON JR, Tayob N, Yang DD, Tralins J, et al
    Local therapy outcomes and toxicity from the (anonymized for review) trial: A phase II randomized trial of adjuvant trastuzumab emtansine vs. paclitaxel in combination with trastuzumab in women with stage I HER2-positive breast cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jan 3. pii: S0360-3016(21)03446.
    PubMed     Abstract available
    
    
    
51. BACHIR B, Anouti S, Jaoude JA, Kayali M, et al
    Evaluation of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Treated with Radiation Therapy and Trastuzumab.
    Int J Radiat Oncol Biol Phys. 2022 Jan 2. pii: S0360-3016(21)03432.
    PubMed     Abstract available
    
    
    
52. SHUMWAY DA, Corbin KS, Mutter RW
    Improving the Therapeutic Ratio Among Older Women With Early Stage Breast Cancer by Reevaluating Adjuvant Radiation Therapy and Hormone Therapy.
    Int J Radiat Oncol Biol Phys. 2022;112:52-55.
    PubMed    
    
    
    December 2021
53. VICINI F, Broughman J, Halima A, Mayo Z, et al
    Delivery of Adjuvant Radiation in 5 Days or Less After Lumpectomy for Breast Cancer: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2021 Dec 15. pii: S0360-3016(21)03233.
    PubMed     Abstract available
    
    
    November 2021
54. SIT D, Lalani N, Chan E, Tran E, et al
    Association between regional nodal irradiation and breast cancer recurrence-free interval for patients with low-risk, node-positive breast cancer.
    Int J Radiat Oncol Biol Phys. 2021 Nov 8. pii: S0360-3016(21)03072.
    PubMed     Abstract available
    
    
    
55. MA DC, Potters L, Lee L, Bloom BF, et al
    Patient-Reported Outcomes Using Automated Chatbot for Breast Cancer Patients Receiving Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
56. LIANG X, Li N, Zhou X, Jin H, et al
    Evaluation of Automated Breast Cancer Contour Propagation From Planning CT to Cone Beam CT Based on Deep Learning.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
57. TAKAYESU J, Sapir E, Xie J, Sun Y, et al
    Survival Outcomes and Symptom Benefit From Palliative Radiotherapy in Breast Cancer Patients With Leptomeningeal Disease.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
58. SHUMWAY JW, Torras M, Hayes KR, Jolly T, et al
    Outcomes of Patients With HER2-Positive Breast Cancer Metastatic to Brain Treated With HER2-Targeted Systemic Therapy and Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
59. MILLIGAN MG, Aitelli A, Mehan WA, Shi DD, et al
    Leptomeningeal Disease in Breast Cancer: Pre-Treatment Prognostic Factors and Outcomes.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
60. SAID BI, Chen H, Jerzak K, Myrehaug SD, et al
    T-DM1 Increases the Risk of SRS-Induced Radiation Necrosis in Her2+ Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
61. PERRON-GAGNON L, Archambault L, Varfalvy N, Piron O, et al
    Breast Deformations Measured With Cone Beam Computed Tomography During Adjuvant Radiotherapy for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
62. LEE JJB, Lee IJ, Choi Y, Jeon MJ, et al
    Clinical Implications of Geometric and Dosimetric Uncertainties Due to Inter- and Intra-Fractional Movement During Volumetric Modulated Arc Therapy for Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
63. GIANTSOUDI D, Lalonde A, Colleen B, Vanbenthuysen L, et al
    Tattoo-Free Set-ups for Breast Cancer Patients Receiving Regional Nodal Irradiation: Evaluation of Accuracy and Time Efficiency.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
64. XIN X, Zhang D, Zhao Y, Wang P, et al
    Overview of the Dosimetry of Free Breathing and Breath Hold Forward Intensity Modulated Treatments in a Large Clinical Series of Left-Sided Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
65. MURAKAMI Y, Murakami Y, Kamima T, Abo N, et al
    Dosimetric Comparison Between 3D Conformal Radiation Therapy Plus Electron Boost and Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Left-Sided Breast Cancer Patients With a Potential Risk of Radiation-Induced Cardiac Toxicity.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
66. MLADKOVA N, Smith TL, Yildiz V, Healy E, et al
    The Impact of Bioabsorbable 3D Fiducial Marker on Radiation Dosimetry and Cosmesis in Early Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
67. FAIRCHILD AM, Hill J, Alhumaid M, Ghosh S, et al
    Palliative Radiotherapy Delivery by a Dedicated Multidisciplinary Supportive Care Team: Facilitating Early Integration of Palliative Care for Patients With Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
68. HILL J, Alhumaid M, Ghosh S, Le A, et al
    Efficiency of Radiotherapy Delivery for Patients With Breast Cancer in a Dedicated Multidisciplinary Palliation Radiation Oncology Clinic.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
69. ALHUMAID M, Hill J, Ghosh S, Watanabe SM, et al
    Comprehensive Assessment of Care Needs During Palliative Radiotherapy Consultation Optimizes Provision of Supportive Care for Patients With Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
70. NICHOLS EM, DeCesaris C, Paulosky K, McAvoy SA, et al
    Cardiac Risk Factors in Black Women With Breast Cancer Undergoing Proton Therapy (PBT): Potential for Increased Therapeutic Gain.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
71. MCGUNIGAL M, Bhatt R, Aghdam N
    Sociodemographic Predictors of Stage IV Breast Cancer Presentation in a Vulnerable Patient Population.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
72. BOYCE-FAPPIANO D, Bedrosian I, Shen Y, Lin HY, et al
    Evaluation of Overall Survival and Barriers to Surgery for Breast Cancer Patients Treated Without Surgery.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
73. GRIFFITH T, Parsons MW, Tward JD, Tao R, et al
    Risk of Secondary Breast Cancer in Female Non-Hodgkin Lymphoma Survivors: 40 Years of Follow-Up Assessed by Treatment Modality.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
74. KINSLOW CJ, Krishnamurthy PB, Sanchez GI, Wang TJC, et al
    Risk of Anaplastic Large Cell Lymphoma After Post-Mastectomy Implant-Reconstruction for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
75. ZHANG Y, Chen F, Jing H, Xu LL, et al
    Radiotherapy Induced Dynamic Changes of Circulating Blood Immune Cell Subsets in Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
76. KANG BH, Jang BS, Kim IA
    Radiosensitivity and Immune Cell Infiltration Signature Predict Clinical Outcome of Patients in the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) Study Cohort.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
77. CHEN F, Jin JY, Nong Y, Wang W, et al
    Radiation Induced Lymphopenia Can Be Predicted by the Effective Dose to the Circulating Immune Cells (EDIC) in Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
78. RAHIMI AS, Kim DN, Leitch M, Gu X, et al
    Early Follow-Up of Multi-Institutional Trial of Phase I Dose Escalation Using Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
79. CHEN C, Zheng S, Cao L, Cai G, et al
    Comparison of Prognosis Between Breast Conserving Therapy and Mastectomy in Early Breast Cancer: A Propensity Score Matching Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
80. ZHAI YR, Wen G, Wang SL, Zhang Y, et al
    Systemic Inflammation-Immune Status Score Predicts the Incidence of Radiation Induced Pneumonitis in Patients With Breast Cancer After Whole Breast Irradiation: A Result From Two Medical Centers.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
81. PINNARO P, Takanen S, Landoni V, Vici P, et al
    Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer: 3 Year-Follow-Up of a Phase II Toxicity Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
82. SMITH AW, Kerns SL, Rowley JP, Moshier E, et al
    Quantifying Risk of Ipsilateral Arm Lymphedema Causing Functional Impairment in Breast Cancer Patients: Results From a Prospective, Multi-Centre International Study of Treatment Toxicity.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
83. MOON JY, Chang JS, Chung SY, Park RH, et al
    Machine Learning Based Analysis of Heart and Cardiac Substructures for Radiation-Induced Cardiac Toxicity From Breast Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
84. JIANG Z, Diao P, Liang Y, Dai K, et al
    A Light Gradient Boosting Machine-Enabled Early Prediction of Cardiotoxicity for Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
85. HALL J, Fried DV, Marks LB, Gupta GP, et al
    Dosimetric and Clinical Factors Associated With Increased Risk of Reconstruction Complications in Patients With Breast Cancer Receiving Post-Mastectomy Radiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
86. ALLALI S, Beddok A, Servois V, Fourquet A, et al
    Assessment of Side Effects of Radiation Therapy in Patients With COVID-19 Treated for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
87. CHUN J, Chang JS, Park I, Kim JS, et al
    Cardiac Substructure Delineation Based on Synthetic Contrast-Enhanced CT Generation Using Deep Convolutional Neural Network in Breast Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
88. LOAP P, Laki F, Beuzeboc P, Fourquet A, et al
    Long-Term Survival and Toxicity in Patients Treated With Radiotherapy for Neuroendocrine Breast Cancer: A Single-Center Experience.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
89. LIAO D, Singh K, Helou J, Fyles A, et al
    Impact of the COVID-19 Pandemic on Radiotherapy Patterns of Practice for Curative Intent Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
90. SUN G, Zhang J, Wang SL, Tang Y, et al
    Tumor-Infiltrating Lymphocytes and Prognosis in Stage I-III Triple-Negative Breast Cancer: A Retrospective Analysis of 258 Patients Treated Without Neoadjuvant Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
91. ZHAO X, Guo N, Ma C, Yan XN, et al
    Mapping of Level I Axillary Lymph Nodes in Patients With Newly Diagnosed Breast Cancer: Optimal Target Delineation and Treatment Techniques in Breast and Level I Axilla Irradiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
92. WARD KA, Muller DA, Dutta SW, Malhi J, et al
    Long-Term Adherence to Adjuvant Endocrine Therapy Following Various Radiotherapy Modalities in Hormone Receptor Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
93. WALLACE AS, Culbert M, Rocque G, Keene KS, et al
    Satisfaction and Regret With Decision Making in Older Women With Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
94. SUN G, Wen G, Zhang YJ, Tang Y, et al
    Risk Factors to Identify the Indication for Regional Nodal Irradiation in T1-2N1M0 Breast Cancer: A Joint Analysis of 4243 Real-World Cases From Two Institutions.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
95. SONG Y, Sun G, Wang S, Zhang J, et al
    Quality of Life After Partial or Whole Breast Irradiation After Breast-Conserving Surgery for Low-Risk Breast Cancer: 1-Year Results of a Phase 2 Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
96. SITTENFELD SMC, Zabor E, Hamilton SN, Kuerer HM, et al
    Impact of Post-Mastectomy Radiation Therapy in Women With T1-2N1M0 Breast Cancer With Sentinel Lymph Node Biopsy Alone.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
97. SIT D, Lalani N, Chan EK, Tran E, et al
    Regional Nodal Irradiation for Low-Risk, Node-Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
98. SHUKLA U, Langner UW, Tan S, Linshaw D, et al
    Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker vs. Surgical Clips for Targeting Breast Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
99. SEOL SW, Pflederer T, Weller L, Goodman CR, et al
    A Comparison of Outcomes in Early Breast Cancer After External Beam Radiotherapy, Intraoperative Radiotherapy, or Observation: A Retrospective Cohort Study Across a Large Health System.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
100. SEOL SW, Weller L, Pflederer T, Goodman CR, et al
     A Comparison of Outcomes in Early-Stage Breast Cancer After External Beam Radiotherapy, Endocrine Therapy, Both, or Neither: A Retrospective Cohort Study Across a Large Health System.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
101. SCHLAFSTEIN A, Torres M, Rupji M, Brown G, et al
     Radiotherapy for Breast Cancer, Systemic Inflammation, and Cancer Recurrence.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
102. RESHKO LB, Pan J, Rai SN, Ajkay N, et al
     Five-Year Report of the Institutional Phase II Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early-Stage Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
103. RAJ R, Jhawar SR, Stover D, Park KU, et al
     De-Escalation of Radiation Therapy in Patients with cT1-T2 (< 3 cm) N0 HER2+ Breast Cancer Treated With Neoadjuvant Systemic Therapy With Pathologic Complete Response at the Time of Breast Conserving Surgery.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
104. MARK RJ, Gorman V, Wolski M, McCullough S, et al
     Five Day Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) in Stage 0-II Breast Cancer: A Report of 218 Cases With Up to 39 Month Follow-Up.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
105. OOI KH, Koh WY, Ho F, Tseng MSF, et al
     Efficacy and Safety of Adjuvant Breast Radiation Therapy for Patients With Early-Stage Breast Cancer: A Systematic Review and Network Meta-Analysis.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
106. MA SJ, Yu B, Oladeru OT, Bartl A, et al
     Evaluation of Adjuvant Radiation and Endocrine Therapy in Elderly Patients with Early-Stage Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
107. LORENZ J, Rizzo M, Patel SA, Kahn ST, et al
     Five-Year Results from a Single Institution Utilizing IORT for Early-Stage Breast Cancer in a Population Comprised of a Majority of African American Women.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
108. GIAP F, Bradley JA, Vega RM, Bates JE, et al
     Treatment of PRIME II Eligible Women With Early-Stage Breast Cancer: A National Cancer Database Analysis.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
109. FAHEY M, Mills MN, Liveringhouse C, Ronica N, et al
     Adherence to Endocrine Therapy Predicts Short-Term Clinical Outcomes for Postmenopausal Women With Luminal B but Not Luminal A Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
110. CHOUDHURY LS, Moran A, Daly ME, Monjazeb AM, et al
     An Analysis of Daily Setup Variation in Prone Breast Radiation of Early-Stage Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
111. CHEVLI NC, Haque W, Tran KT, Farach AM, et al
     21-Gene Recurrence Score Predictive for Patients Most Likely to Benefit From Postoperative Radiation Following Breast Conserving Surgery for T1N0 Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
112. CHEN F, Yu H, Nong Y, Jing H, et al
     Risk Factors for Radiation Induced Lymphopenia in Patients With Breast Cancer: Does Radiotherapy Technique Matter?
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
113. SYED ANM, Chang H, Hodge W, Reiner SD, et al
     Ethnic and Racial (E/R) Differences in Early-Stage Breast Cancer Patients (Pts) Successfully Treated With Intra-Operative Radiation Therapy (IORT) Using Electronic Brachytherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
114. MUSHONGA M
     Hypofractionated Radiotherapy for Breast Cancer: Findings From an International ESTRO-GIRO Survey.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
115. LIN JY, Yang X, Miller AH, Godette KD, et al
     A Pilot Study of Hypofractionated Simultaneous Integrated Boost Radiotherapy in Stage 0-IIIB Breast Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
116. KIM DY, Park E, Heo CY, Jin US, et al
     Hypofractionated vs. Conventional Radiotherapy in Breast Cancer Patients Who Underwent Breast Reconstruction: Toxicity Analysis.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
117. ROSTOM Y, Mahmoud N, Abdelmoneim SE, Shaker M, et al
     Outcomes of Adjuvant Hypofractionated Radiotherapy in the Treatment of Post-Mastectomy Breast Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
118. ZHAO X, Xuan L, Yin J, Tang Y, et al
     Radiotherapy in Breast Cancer Patients With Isolated Regional Recurrence After Mastectomy: A Joint Analysis of 144 Cases From Two Institutions.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
119. WANG M, Chen J, Qi WX, Cao L, et al
     Using Inflammatory Blood Markers as Useful Prognostic Factors in Patients Undergoing Neo-Adjuvant Therapy for Stage II-III Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
120. PURSWANI J, Oh C, Xiao J, Barbee D, et al
     Boost to Unresectable Nodal Disease in Locally Advanced Breast Cancer: Outcomes and Toxicity.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
121. NARAYAN P, Flynn J, Zhang Z, Gillespie EF, et al
     Perineural Invasion as a Risk Factor for Locoregional Recurrence of Invasive Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
122. KIM BH, Cho MJ, Kwon J
     Potential Intrinsic Subtype Dependence on the Association Between Metformin Use and Survival in Surgically Resected Breast Cancer: A Korean National Population-Based Study.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
123. KIM JK, Karp JM, Gerber NK
     Isolated Tumor Cells and Micrometastatic Nodal Disease in Breast Cancer Patients After Neoadjuvant Chemotherapy: Is Post Mastectomy Radiation Therapy Indicated?
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
124. ANDRING LM, Diao K, Sun SX, Patel MM, et al
     Prognostic Factors in Breast Cancer Patients With Clinical N3b (Ipsilateral Internal Mammary and Axillary) Disease.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
125. CHU CN, Chan KHC, Wu RSC
     FR-101 Dressing May Alleviate Radiation-Irritated Skin After Radiotherapy in Breast Cancer Patients - A Pilot Clinical Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
126. MO A, Chung J, Eichler J, Yukelis S, et al
     Breast Cancer Survivorship Care During the COVID-19 Pandemic Within an Urban New York Hospital System.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
127. YUSUF MB, Pan J, Rai SN, Eldredge-Hindy HB, et al
     Financial Toxicity in Women with Breast Cancer Receiving Radiotherapy: Final Results of a Prospective Observational Study.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
128. WEISS M, Danese S, Ruiz KA, Kjelstrom S, et al
     A Survey of Breast Cancer Patients' Use of Cannabis During Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
129. YU J, Wroe A, Acosta M, Fagundes MA, et al
     Impact of Dose Calculation Algorithm on Skin Dose for Breast Cancer Treated With Intensity Modulated Proton Therapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
130. DAI Z, Liang X, Zhu L, Tan J, et al
     Deep Learning-Based Automatic Delineation of Target Volumes and Organs at Risk of Breast Cancer for On-Line Dosimetric Evaluation.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
131. BYUN HK, Chang JS, Choi MS, Chun J, et al
     Evaluation of Deep Learning-Based Auto-Segmentation of Organs-at-Risk for Breast Cancer Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
132. LOAP P, Loirat D, Berger F, Rodrigues M, et al
     One-Year Toxicity Report of the RADIOPARP Phase I Trial Evaluating Olaparib With Radiotherapy for Triple Negative Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
133. SERRA D, Fleishman S, White C, Welsh C, et al
     Effectiveness of Traditional Acupuncture in Reducing the Severity of Hot Flashes Reported by Breast Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
134. BACHIR B, Anouti S, Jaoude JA, Kayali M, et al
     Evaluation of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Treated With Radiation Therapy and Trastuzumab.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
135. NELSON CJ, Ahern T, Brennan S, Kerrigan C, et al
     A Pilot Study to Quantify Breast Lymphedema for Patients Undergoing Breast Conserving Therapy (BCT) for Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
136. MANKUZHY N, Grzywacz VP 2nd, Quinn TJ, Jawad MS, et al
     Thirty-Year Single Institution Experience of Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
137. CHEN S, Sun G, Wang S, Fang H, et al
     Delay in Initiating Postmastectomy Radiotherapy is Associated With Inferior Clinical Oncologic Outcomes for High-Risk Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
138. FORSTER T, Hommertgen A, Hafner MF, Arians N, et al
     Quality of Life After Simultaneously Integrated Boost With Intensity-Modulated vs. Conventional Radiotherapy Followed by Sequential Boost for Adjuvant Treatment of Breast Cancer: 2-Year Results of the Multicenter Randomized IMRT-MC2 Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
139. BELLON JR, Tayob N, Burstein HJ, Partridge A, et al
     Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033), a Phase II Randomized Trial of Adjuvant T-DM1 vs. TH in Women With Stage I HER2 Positive Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
140. CHOI IJ, Khan AJ, Mah D, McCormick B, et al
     Proton Reirradiation for Recurrent or New Primary Breast Cancer in the Setting of Prior Breast Irradiation.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
141. DIAA M, Mohammmed T, Abd Elshaheed WH, Bayomy M, et al
     The Impact of Regional Nodal Irradiation on the Outcomes After Neoadjuvant Chemotherapy in Node Positive Breast Cancer Patients With ypN0: Interim Analysis of a Prospective Randomized Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
142. DIAO K, Andring LM, Barcenas CH, Singh P, et al
     Outcomes After Multimodality Therapy in Modern Breast Cancer Patients Presenting With Clinical N3c Supraclavicular Node Involvement.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
143. NAOUM GE, Ioakeim-Ioannidou M, Shui AM, Salama L, et al
     Analysis of Radiation Modality and Timing on Complication Rates in Breast Cancer Patients Receiving Two-Stage Expander/Implant Reconstruction.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
144. KIM YB, Byun HK, Kim DY, Ahn SJ, et al
     Elective Internal Mammary Node Irradiation in Women With Node-Positive Breast Cancer: Results of a Randomized, Phase 3 Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     October 2021
145. JAGSI R, Griffith KA, Vicini FA, Abu-Isa E, et al
     Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort.
     Int J Radiat Oncol Biol Phys. 2021 Oct 27. pii: S0360-3016(21)02918.
     PubMed     Abstract available
     
     
     
146. RAHIMI A, Simmons A, Kim DN, Leitch M, et al
     Preliminary Results of Multi-Institutional Phase I Dose Escalation Trial Using Single Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer: Dose Escalated Single Fraction Stereotactic PBI.
     Int J Radiat Oncol Biol Phys. 2021 Oct 19. pii: S0360-3016(21)02916.
     PubMed     Abstract available
     
     
     
147. SAULSBERRY L, Liao C, Huo D
     Hypofractionated Radiotherapy for Breast Cancer: Financial Risk and Expenditures in the U.S. 2008-2017: Expenditure of Hypofractionated Radiotherapy.
     Int J Radiat Oncol Biol Phys. 2021 Oct 9. pii: S0360-3016(21)02901.
     PubMed     Abstract available
     
     
     
148. CUTTINO LW, McCall L, Kubicky C, Ballman KV, et al
     The Feasibility of Radiotherapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.
     Int J Radiat Oncol Biol Phys. 2021 Oct 8. pii: S0360-3016(21)02872.
     PubMed    
     
     
     
149. JAGSI R, Griffith KA, Moran JM, Matuszak MM, et al
     Comparative Effectiveness Analysis of 3D-Conformal Radiotherapy versus Intensity Modulated Radiotherapy (IMRT) in a Prospective Multicenter Cohort of Breast Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2021 Oct 8. pii: S0360-3016(21)02871.
     PubMed     Abstract available
     
     
     
150. VAN VELZEN SGM, Gal R, Teske AJ, van der Leij F, et al
     AI-based radiation dose quantification for estimation of heart disease risk in breast cancer survivors after radiotherapy.
     Int J Radiat Oncol Biol Phys. 2021 Oct 5. pii: S0360-3016(21)02791.
     PubMed     Abstract available
     
     
     
151. KIM DY, Park E, Heo CY, Jin US, et al
     Influence of Hypofractionated versus Conventional Fractionated Postmastectomy Radiotherapy in Breast Cancer Patients with Reconstruction.
     Int J Radiat Oncol Biol Phys. 2021 Oct 2. pii: S0360-3016(21)02835.
     PubMed     Abstract available
     
     
     
152. WENG JK, Lei X, Schlembach P, Bloom ES, et al
     Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.
     Int J Radiat Oncol Biol Phys. 2021;111:360-370.
     PubMed     Abstract available
     
     
     August 2021
153. DIAO K, Andring LM, Barcenas CH, Singh P, et al
     Contemporary Outcomes after Multimodality Therapy in Breast Cancer Patients Presenting with Ipsilateral Supraclavicular Node Involvement.
     Int J Radiat Oncol Biol Phys. 2021 Aug 20. pii: S0360-3016(21)02714.
     PubMed     Abstract available
     
     
     June 2021
154. RESHKO LB, Pan J, Rai SN, Ajkay N, et al
     Final Analysis of a Phase II Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early Stage Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021 Jun 25. pii: S0360-3016(21)00744.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: